Literature DB >> 19052852

Human immune memory to yellow fever and smallpox vaccination.

Jens Wrammert1, Joe Miller, Rama Akondy, Rafi Ahmed.   

Abstract

BACKGROUND: Establishment of immunological memory is a hallmark of adaptive immune responses and the biological mechanism for the success of vaccines. However, in humans, much of our knowledge about adaptive immune responses derives from studies of chronic viral infections.
OBJECTIVE: Here, we summarize the work of our laboratory and others on B and T cell responses and the establishment and maintenance of immune memory after acute viral infections induced by vaccination with two of the most successful vaccines to date, the yellow fever and the smallpox vaccines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052852     DOI: 10.1007/s10875-008-9267-3

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  50 in total

Review 1.  Cellular immune responses to HIV.

Authors:  A J McMichael; S L Rowland-Jones
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

2.  Autoradiographic observations of plasma cell formation.

Authors:  J C SCHOOLEY
Journal:  J Immunol       Date:  1961-03       Impact factor: 5.422

3.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

4.  Lifetime of plasma cells in the bone marrow.

Authors:  R A Manz; A Thiel; A Radbruch
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

Review 5.  Immunological memory and protective immunity: understanding their relation.

Authors:  R Ahmed; D Gray
Journal:  Science       Date:  1996-04-05       Impact factor: 47.728

6.  In vivo study of the HC-TN strain of hepatitis C virus recovered from a patient with fulminant hepatitis: RNA transcripts of a molecular clone (pHC-TN) are infectious in chimpanzees but not in Huh7.5 cells.

Authors:  Akito Sakai; Shingo Takikawa; Robert Thimme; Jean-Christophe Meunier; Hans Christian Spangenberg; Sugantha Govindarajan; Patrizia Farci; Suzanne U Emerson; Francis V Chisari; Robert H Purcell; Jens Bukh
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.

Authors:  M T Roos; R A van Lier; D Hamann; G J Knol; I Verhoofstad; D van Baarle; F Miedema; P T Schellekens
Journal:  J Infect Dis       Date:  2000-07-24       Impact factor: 5.226

8.  Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.

Authors:  Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

9.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  15 in total

Review 1.  Advances and controversies in yellow fever vaccination.

Authors:  Emile F F Jonker; Leonardus G Visser; Anna H Roukens
Journal:  Ther Adv Vaccines       Date:  2013-11

2.  Intrinsic differences in the initiation of B cell receptor signaling favor responses of human IgG(+) memory B cells over IgM(+) naive B cells.

Authors:  Angel M Davey; Susan K Pierce
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

3.  Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression.

Authors:  Alice E Wiedeman; Virginia S Muir; Mario G Rosasco; Hannah A DeBerg; Scott Presnell; Bertrand Haas; Matthew J Dufort; Cate Speake; Carla J Greenbaum; Elisavet Serti; Gerald T Nepom; Gabriele Blahnik; Anna M Kus; Eddie A James; Peter S Linsley; S Alice Long
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

4.  High efficiency human memory B cell assay and its application to studying Plasmodium falciparum-specific memory B cells in natural infections.

Authors:  Greta E Weiss; Francis M Ndungu; Noah McKittrick; Shanping Li; Domtila Kimani; Peter D Crompton; Kevin Marsh; Susan K Pierce
Journal:  J Immunol Methods       Date:  2011-09-22       Impact factor: 2.303

5.  Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins.

Authors:  Eddie A James; Rebecca E LaFond; Theresa J Gates; Duy T Mai; Uma Malhotra; William W Kwok
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

6.  B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant.

Authors:  Jane Baer; Felix Santiago; Hongmei Yang; Hulin Wu; Jeanne Holden-Wiltse; John Treanor; David J Topham
Journal:  Vaccine       Date:  2009-11-21       Impact factor: 3.641

7.  A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity.

Authors:  Srilatha Edupuganti; Rachel B Eidex; Harry Keyserling; Rama S Akondy; Robert Lanciotti; Walter Orenstein; Carlos del Rio; Yi Pan; Troy Querec; Harvey Lipman; Alan Barrett; Rafi Ahmed; Dirk Teuwen; Martin Cetron; Mark J Mulligan
Journal:  Am J Trop Med Hyg       Date:  2012-12-03       Impact factor: 2.345

8.  Use it or lose it: establishment and persistence of T cell memory.

Authors:  Katherine Kedzierska; Sophie A Valkenburg; Peter C Doherty; Miles P Davenport; Vanessa Venturi
Journal:  Front Immunol       Date:  2012-11-27       Impact factor: 7.561

9.  The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.

Authors:  Michele Tameris; Hennie Geldenhuys; Angelique KanyKany Luabeya; Erica Smit; Jane E Hughes; Samantha Vermaak; Willem A Hanekom; Mark Hatherill; Hassan Mahomed; Helen McShane; Thomas J Scriba
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

10.  Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell function.

Authors:  One B Dintwe; Cheryl L Day; Erica Smit; Elisa Nemes; Clive Gray; Michele Tameris; Helen McShane; Hassan Mahomed; Willem A Hanekom; Thomas J Scriba
Journal:  Eur J Immunol       Date:  2013-07-08       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.